Comparison of models for bubonic plague reveals unique pathogen adaptations to the dermis

Infection and Immunity

Volumn 83, Issue 7, 2015, Pages 2855-2861

  Gonzalez, Rodrigo J ^a,b   Weening, Eric H ^a   Lane, M Chelsea ^a,c   Miller, Virginia L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL KINETICS; BACTERIAL LOAD; COMPARATIVE STUDY; CONTROLLED STUDY; DELETION MUTANT; DERMIS; FEMALE; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INOCULATION; LYMPH NODE; MOUSE; NONHUMAN; PATHOGENESIS; PLAGUE; PRIORITY JOURNAL; SURVIVAL RATE; ADAPTATION; ANIMAL; C57BL MOUSE; DISEASE COURSE; DISEASE MODEL; MICROBIOLOGY; PHYSIOLOGY; SURVIVAL ANALYSIS; YERSINIA PESTIS;

ADAPTATION, BIOLOGICAL; ANIMALS; DERMIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; MICE, INBRED C57BL; PLAGUE; SURVIVAL ANALYSIS; YERSINIA PESTIS;

EID: 84930986846     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00140-15     Document Type: Article

References (34)

1. Chong SZ, Evrard M, Ng LG. 2013. Lights, camera, and action: vertebrate skin sets the stage for immune cell interaction with arthropod-vectored pathogens. Front Immunol 4:286. http://dx.doi.org/10.3389/fimmu.2013 .00286.
2. Nestle FO, Di Meglio P, Qin J-Z, Nickoloff BJ. 2009. Skin immune sentinels in health and disease. Nat Rev Immunol 9:679-691. http://dx .doi.org/10.1038/nri2622.
3. Teunissen MBM, Haniffa M, Collin MP. 2012. Insight into the immunobiology of human skin and functional specialization of skin dendritic cell subsets to innovate intradermal vaccination design. Curr Top Microbiol Immunol 351:25-76. http://dx.doi.org/10.1007/82_2011_169.
4. Frischknecht F. 2007. The skin as interface in the transmission of arthropod- borne pathogens. Cell Microbiol 9:1630-1640. http://dx.doi.org/10 .1111/j.1462-5822.2007.00955.x.
5. Sebbane F, Jarrett CO, Gardner D, Long D, Hinnebusch BJ. 2006. Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci U S A 103:5526-5530. http://dx.doi.org/10.1073/pnas.0509544103.
6. Choumet V, Attout T, Chartier L, Khun H, Sautereau J, Robbe-Vincent A, Brey P, Huerre M, Bain O. 2012. Visualizing non infectious and infectious Anopheles gambiae blood feedings in naive and salivaimmunized mice. PLoS One 7:e50464. http://dx.doi.org/10.1371/journal .pone.0050464.
7. Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, Ribeiro J, Sacks DL. 1998. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med 188:1941-1953. http://dx.doi.org/10.1084 /jem.188.10.1941.
8. Bos KI, Schuenemann VJ, Golding GB, Burbano HA, Waglechner N, Coombes BK, McPhee JB, DeWitte SN, Meyer M, Schmedes S, Wood J, Earn DJD, Herring DA, Bauer P, Poinar HN, Krause J. 2011. A draft genome of Yersinia pestis from victims of the Black Death. Nature 478: 506-510. http://dx.doi.org/10.1038/nature10549.
9. Butler T. 2013. Plague gives surprises in the first decade of the 21st century in the United States and worldwide. Am J Trop Med Hyg 89:788-793. http://dx.doi.org/10.4269/ajtmh.13-0191.
10. Wimsatt J, Biggins DE. 2009. A review of plague persistence with special emphasis on fleas. J Vector Borne Dis 46:85-99.
11. Gonzalez RJ, Lane MC, Wagner NJ, Weening EH, Miller VL. 2015. Dissemination of a highly virulent pathogen: tracking the early events that define infection. PLoS Pathog 11:e1004587. http://dx.doi.org/10.1371 /journal.ppat.1004587.
12. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ. 2005. Kinetics of disease progression and host response in a rat model of bubonic plague.Am J Pathol 166:1427-1439. http://dx.doi.org/10.1016/S0002-9440(10)62360-7.
13. Demeure CE, Blanchet C, Fitting C, Fayolle C, Khun H, Szatanik M, Milon G, Panthier J-J, Jaubert J, Montagutelli X, Huerre M, Cavaillon J-M, Carniel E. 2012. Early systemic bacterial dissemination and a rapid innate immune response characterize genetic resistance to plague of SEG mice. J Infect Dis 205:134-143. http://dx.doi.org/10.1093/infdis/jir696.
14. Lenz JD, Lawrenz MB, Cotter DG, Lane MC, Gonzalez RJ, Palacios M, Miller VL. 2011. Expression during host infection and localization of Yersinia pestis autotransporter proteins. J Bacteriol 193:5936-5949. http: //dx.doi.org/10.1128/JB.05877-11.
15. Abu Khweek A, Fetherston JD, Perry RD. 2010. Analysis of HmsH and its role in plague biofilm formation. Microbiology 156:1424-1438. http: //dx.doi.org/10.1099/mic.0.036640-0.
16. Oyston PC, Dorrell N, Williams K, Li SR, Green M, Titball RW, Wren BW. 2000. The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis. Infect Immun 68:3419-3425. http://dx.doi.org/10.1128/IAI.68.6.3419-3425.2000.
17. Hinnebusch BJ. 2005. The evolution of flea-borne transmission in Yersinia pestis. Curr Issues Mol Biol 7:197-212.
18. Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice MB, Sebaihia M, James KD, Churcher C, Mungall KL, Baker S, Basham D, Bentley SD, Brooks K, Cerdeño-Tárraga AM, Chillingworth T, Cronin A, Davies RM, Davis P, Dougan G, Feltwell T, Hamlin N, Holroyd S, Jagels K, Karlyshev AV, Leather S, Moule S, Oyston PC, Quail M, Rutherford K, Simmonds M, Skelton J, Stevens K, Whitehead S, Barrell BG. 2001. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413:523-527. http://dx.doi.org/10.1038/35097083.
19. Doll JM, Zeitz PS, Ettestad P, Bucholtz AL, Davis T, Gage K. 1994. Cat-transmitted fatal pneumonic plague in a person who traveled from Colorado to Arizona. Am J Trop Med Hyg 51:109-114.
20. Cathelyn JS, Crosby SD, Lathem WW, Goldman WE, Miller VL. 2006. RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague. Proc Natl Acad Sci U S A 103:13514-13519. http://dx.doi .org/10.1073/pnas.0603456103.
21. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640-6645. http://dx.doi.org/10.1073/pnas.120163297.
22. Walters MS, Lane MC, Vigil PD, Smith SN, Walk ST, Mobley HLT. 2012. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection. mBio 3(1):e00303-11. http://dx.doi .org/10.1128/mBio.00303-11.
23. Van den Broeck W, Derore A, Simoens P. 2006. Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 312:12-19. http://dx.doi.org/10.1016/j.jim.2006.01.022.
24. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
25. Guinet F, Carniel E. 2003. A technique of intradermal injection of Yersinia to study Y. pestis physiopathology. Adv Exp Med Biol 529:73-78.
26. Bosio CF, Jarrett CO, Gardner D, Hinnebusch BJ. 2012. Kinetics of innate immune response to Yersinia pestis after intradermal infection in a mouse model. Infect Immun 80:4034-4045. http://dx.doi.org/10.1128 /IAI.00606-12.
27. Weening EH, Cathelyn JS, Kaufman G, Lawrenz MB, Price P, Goldman WE, Miller VL. 2011. The dependence of the Yersinia pestis capsule on pathogenesis is influenced by the mouse background. Infect Immun 79: 644-652. http://dx.doi.org/10.1128/IAI.00981-10.
28. O'Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber RW, Mortimer PS, Purushotham AD, Peters AM. 2004. Finding an optimal method for imaging lymphatic vessels of the upper limb. Eur J Nucl Med Mol Imaging 31:555-563. http://dx.doi.org/10.1007/s00259 -003-1399-3.
29. Shayan R, Achen MG, Stacker SA. 2006. Lymphatic vessels in cancer metastasis: bridging the gaps. Carcinogenesis 27:1729-1738. http://dx.doi .org/10.1093/carcin/bgl031.
30. Kersey TW, Van Eyk J, Lannin DR, Chua AN, Tafra L. 2001. Comparison of intradermal and subcutaneous injections in lymphatic mapping. J Surg Res 96:255-259. http://dx.doi.org/10.1006/jsre.2000.6075.
31. Combadiere B, Liard C. 2011. Transcutaneous and intradermal vaccination. Hum Vaccin 7:811-827. http://dx.doi.org/10.4161/hv.7.8.16274.
32. Bonnotte B, Gough M, Phan V, Ahmed A, Chong H, Martin F, Vile RG. 2003. Intradermal injection, as opposed to subcutaneous injection, enhances immunogenicity and suppresses tumorigenicity of tumor cells. Cancer Res 63:2145-2149.
33. Cubas R, Zhang S, Kwon S, Sevick-Muraca EM, Li M, Chen C, Yao Q. 2009. Virus-like particle (VLP) lymphatic trafficking and immune response generation after immunization by different routes. J Immunother 32:118-128. http://dx.doi.org/10.1097/CJI.0b013e31818f13c4.
34. Liard C, Munier S, Arias M, Joulin-Giet A, Bonduelle O, Duffy D, Shattock RJ, Verrier B, Combadiere B. 2011. Targeting of HIV-p24 particle-based vaccine into differential skin layers induces distinct arms of the immune responses. Vaccine 29:6379-6391. http://dx.doi.org/10.1016 /j.vaccine.2011.04.080.